Published on October 5, 2009 at 9:08 AM
Arrayit Corporation (OTCBB: ARYC), a life sciences and health care technology innovator, announces that on October 1st, 2009, the company deployed its next-generation proteomics platform to customers working in the areas of proteomics and in vitro molecular diagnostics.
Arrayit's new proteomics platform provides a patented and comprehensive instrumentation, software and consumables solution for peptide microarray analysis. Peptides are synthetic versions of proteins, the body's ultimate information messengers that carry out instructions encoded by the genes in the human genome. Peptide microarrays allow scientists and doctors to explore the protein world with pinpoint precision.
"We are pleased at the rate of technological innovation taking place in our laboratories," states Rene Schena, CEO and co-founder of Arrayit Corp. "Our next-generation proteomics tools are complimentary to advances in solid phase DNA sequencing, opening up exciting new frontiers in basic research and diagnostics."
SOURCE: Arrayit Corporation